|
Gene: CLUH |
Gene summary for CLUH |
Gene summary. |
Gene information | Species | Human | Gene symbol | CLUH | Gene ID | 23277 |
Gene name | clustered mitochondria homolog | |
Gene Alias | CLU1 | |
Cytomap | 17p13.3 | |
Gene Type | protein-coding | GO ID | GO:0006996 | UniProtAcc | O75153 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23277 | CLUH | HTA11_347_2000001011 | Human | Colorectum | AD | 3.85e-02 | 2.37e-01 | -0.1954 |
23277 | CLUH | HTA11_1391_2000001011 | Human | Colorectum | AD | 6.26e-03 | 4.15e-01 | -0.059 |
23277 | CLUH | HTA11_866_3004761011 | Human | Colorectum | AD | 2.91e-06 | 3.68e-01 | 0.096 |
23277 | CLUH | HTA11_7663_2000001011 | Human | Colorectum | SER | 1.33e-02 | 3.73e-01 | 0.0131 |
23277 | CLUH | HTA11_6801_2000001011 | Human | Colorectum | SER | 2.51e-02 | 6.11e-01 | 0.0171 |
23277 | CLUH | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.35e-04 | 2.99e-01 | 0.0674 |
23277 | CLUH | A015-C-203 | Human | Colorectum | FAP | 2.56e-14 | 4.28e-01 | -0.1294 |
23277 | CLUH | A015-C-204 | Human | Colorectum | FAP | 9.99e-05 | 4.86e-01 | -0.0228 |
23277 | CLUH | A014-C-040 | Human | Colorectum | FAP | 3.77e-02 | 5.21e-01 | -0.1184 |
23277 | CLUH | A002-C-205 | Human | Colorectum | FAP | 1.86e-04 | 7.49e-02 | -0.1236 |
23277 | CLUH | A015-C-006 | Human | Colorectum | FAP | 5.33e-07 | 4.03e-01 | -0.0994 |
23277 | CLUH | A015-C-106 | Human | Colorectum | FAP | 4.21e-04 | 2.05e-01 | -0.0511 |
23277 | CLUH | A002-C-114 | Human | Colorectum | FAP | 2.29e-04 | 1.99e-01 | -0.1561 |
23277 | CLUH | A015-C-104 | Human | Colorectum | FAP | 2.11e-11 | 3.00e-01 | -0.1899 |
23277 | CLUH | A015-C-202 | Human | Colorectum | FAP | 2.90e-03 | 3.45e-01 | -0.0849 |
23277 | CLUH | A002-C-016 | Human | Colorectum | FAP | 9.27e-04 | -1.94e-02 | 0.0521 |
23277 | CLUH | A015-C-002 | Human | Colorectum | FAP | 1.31e-03 | 3.17e-01 | -0.0763 |
23277 | CLUH | A002-C-116 | Human | Colorectum | FAP | 3.90e-07 | -5.53e-02 | -0.0452 |
23277 | CLUH | A014-C-008 | Human | Colorectum | FAP | 2.47e-03 | 2.57e-01 | -0.191 |
23277 | CLUH | A018-E-020 | Human | Colorectum | FAP | 9.69e-03 | 6.02e-02 | -0.2034 |
Page: 1 2 3 4 5 6 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00516463 | Esophagus | ESCC | mitochondrion localization | 35/8552 | 50/18723 | 4.33e-04 | 2.44e-03 | 35 |
GO:0051646 | Liver | HCC | mitochondrion localization | 34/7958 | 50/18723 | 2.38e-04 | 1.79e-03 | 34 |
GO:0048311 | Liver | HCC | mitochondrion distribution | 12/7958 | 16/18723 | 8.74e-03 | 3.40e-02 | 12 |
GO:00516462 | Oral cavity | OSCC | mitochondrion localization | 28/7305 | 50/18723 | 1.10e-02 | 3.72e-02 | 28 |
GO:005164611 | Skin | cSCC | mitochondrion localization | 22/4864 | 50/18723 | 4.31e-03 | 2.27e-02 | 22 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CLUH | SNV | Missense_Mutation | c.3331N>A | p.Gly1111Arg | p.G1111R | O75153 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-VQ-A8DT-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | fluorouracil | PD | |
CLUH | SNV | Missense_Mutation | c.827N>A | p.Arg276His | p.R276H | O75153 | protein_coding | tolerated(0.06) | benign(0.321) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response | ||
CLUH | SNV | Missense_Mutation | novel | c.3155N>A | p.Arg1052Gln | p.R1052Q | O75153 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-VQ-A8PB-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | CR |
CLUH | SNV | Missense_Mutation | novel | c.2878N>C | p.Asp960His | p.D960H | O75153 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-VQ-A91D-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
CLUH | deletion | Frame_Shift_Del | novel | c.976delN | p.Gln326ArgfsTer80 | p.Q326Rfs*80 | O75153 | protein_coding | TCGA-BR-8078-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
CLUH | insertion | Frame_Shift_Ins | rs752224729 | c.1324dupG | p.Asp442GlyfsTer99 | p.D442Gfs*99 | O75153 | protein_coding | TCGA-HU-A4GQ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | ||
CLUH | insertion | Frame_Shift_Ins | rs752224729 | c.1324_1325insG | p.Asp442GlyfsTer99 | p.D442Gfs*99 | O75153 | protein_coding | TCGA-MX-A5UJ-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
CLUH | SNV | Missense_Mutation | c.3082C>A | p.Arg1028Ser | p.R1028S | O75153 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-EM-A22J-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |